The International Myopia Institute White Paper Findings inspires discussion at ARVO 2019

The International Myopia Institute White Paper Findings inspires discussion at ARVO 2019


The International Myopia Institute Report on the White Paper Findings was a featured session at the prestigious Association for Research in Vision and Ophthalmology (ARVO) meeting held on the 29th April 2019 in Vancouver, moderated by Professor Serge Resnikoff and Padmaja Sankaridurg.

It was well attended by over 350 scientists and clinical researchers who were able to listen to the findings and how they translated into research, clinical trials and patient management, followed by and open discussion with the leaders of each of the following committees: Definitions and classifications (Professor Ian Flitcroft); Experimental models and emmetropization (Professor David Troilo); Clinical trials and instrumentation (Dr Nicola Logan); and Genetics (Professor Caroline Klaver).

The idea and definition of “pre-myopia” is a new concept published in the papers was also discussed at length during this session, where a child may be emmetropic but displays all the risk factors of developing myopia. Future research efforts will need to be directed towards this to identify them and evaluate whether treatments can be developed and directed to them.

This was the first session following the publication of the white papers in the February special issue of IOVS and it was an opportunity for members of the research community to further discuss the contents.

The International Myopia Institute was founded by Professor Brien Holden following the WHO Meeting on Myopia held in Sydney in 2015, to continue the efforts of advancing myopia research and advocacy of myopia and high myopia as public health issues, by bringing together a multidisciplinary group of experts to identify gaps in research and generate consensus across the diverse area of myopia to ultimately advance patient care.

“The International Myopia Institute has been successful in bringing together all the experts in myopia in an open and collaborative forum to discuss and generate consensus by gathering the evidence across a massive area of research. The outcome has been a of standardization definitions, making recommendations on conducting research, and patient management. This allows for the systematic management of patients, collection of public health data as well as allowing for easier comparison of research studies. These white papers will also form the basis of the forthcoming WHO Vision Report and future updates of the International Classification of Disease (ICD). We are now planning to disseminate our findings more widely and plan to tackle areas not covered initially,” Dr Monica Jong (Executive Director of IMI).

The white papers were written and reviewed rigorously by over 85 experts and the complete process took almost two years to complete.

Please access them here

For more information about the IMI and joining, please go to https://


03 June 2019


Innovation and Industry
©2019 Global Myopia Centre. A Brien Holden Vision Institute Limited Initiative. All Rights Reserved.